REFINED USES OF NEOSTEN IN OSTEOPOROSIS MANAGEMENT

Neosten 在骨质疏松症治疗中的精细应用

• 批准号: 6567649
• 负责人: CHARLES Y.C PAK
• 金额: $ 32.14万
• 依托单位: UT SOUTHWESTERN MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-12-01 至 2002-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6567649
• 关键词: calcium; citrates; clinical research; combination chemotherapy; diphosphonate; drug design /synthesis /production; drug screening /evaluation; human subject; human therapy evaluation; ingested fluoride therapy; osteoporosis; skeletal disorder chemotherapy; slow release drug

The goals of this project are to improve the efficacy of Neosten treatment by adding a bisphosphonate, and to simplify the Neosten treatment by using a new formulation of sustained-release sodium fluoride combined with Ca citrate.

这个项目的目标是提高Neosten的效率 通过添加双膦酸根进行处理，并简化新的 使用缓释钠的新配方进行治疗 氟化物与柠檬酸钙配伍。